Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis. / Von Wilamowitz-Moellendorff, Alexander; Hunter, Roger W.; García-Rocha, Mar; Kang, Li; López-Soldado, Iliana; Lantier, Louise; Patel, Kashyap; Peggie, Mark W.; Martínez-Pons, Carlos; Voss, Martin; Calbó, Joaquim; Cohen, Patricia T.W.; Wasserman, David H.; Guinovart, Joan J.; Sakamoto, Kei.
In: Diabetes, Vol. 62, No. 12, 01.12.2013, p. 4070-4082.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis
AU - Von Wilamowitz-Moellendorff, Alexander
AU - Hunter, Roger W.
AU - García-Rocha, Mar
AU - Kang, Li
AU - López-Soldado, Iliana
AU - Lantier, Louise
AU - Patel, Kashyap
AU - Peggie, Mark W.
AU - Martínez-Pons, Carlos
AU - Voss, Martin
AU - Calbó, Joaquim
AU - Cohen, Patricia T.W.
AU - Wasserman, David H.
AU - Guinovart, Joan J.
AU - Sakamoto, Kei
PY - 2013/12/1
Y1 - 2013/12/1
N2 - The liver responds to an increase in blood glucose levels in the postprandial state by uptake of glucose and conversion to glycogen. Liver glycogen synthase (GYS2), a key enzyme in glycogen synthesis, is controlled by a complex interplay between the allosteric activator glucose-6-phosphate (G6P) and reversible phosphorylation through glycogen synthase kinase-3 and the glycogen-associated form of protein phosphatase 1. Here, we initially performed mutagenesis analysis and identified a key residue (Arg582) required for activation of GYS2 by G6P. We then used GYS2 Arg582Ala knockin (+/R582A) mice in which G6Pmediated GYS2 activation had been profoundly impaired (60-70%), while sparing regulation through reversible phosphorylation. R582A mutant-expressing hepatocytes showed significantly reduced glycogen synthesis with glucose and insulin or glucokinase activator, which resulted in channeling glucose/G6P toward glycolysis and lipid synthesis. GYS2+/R582A mice were modestly glucose intolerant and displayed significantly reduced glycogen accumulation with feeding or glucose load in vivo. These data show that G6P-mediated activation of GYS2 plays a key role in controlling glycogen synthesis and hepatic glucose-G6P flux control and thus whole-body glucose homeostasis.
AB - The liver responds to an increase in blood glucose levels in the postprandial state by uptake of glucose and conversion to glycogen. Liver glycogen synthase (GYS2), a key enzyme in glycogen synthesis, is controlled by a complex interplay between the allosteric activator glucose-6-phosphate (G6P) and reversible phosphorylation through glycogen synthase kinase-3 and the glycogen-associated form of protein phosphatase 1. Here, we initially performed mutagenesis analysis and identified a key residue (Arg582) required for activation of GYS2 by G6P. We then used GYS2 Arg582Ala knockin (+/R582A) mice in which G6Pmediated GYS2 activation had been profoundly impaired (60-70%), while sparing regulation through reversible phosphorylation. R582A mutant-expressing hepatocytes showed significantly reduced glycogen synthesis with glucose and insulin or glucokinase activator, which resulted in channeling glucose/G6P toward glycolysis and lipid synthesis. GYS2+/R582A mice were modestly glucose intolerant and displayed significantly reduced glycogen accumulation with feeding or glucose load in vivo. These data show that G6P-mediated activation of GYS2 plays a key role in controlling glycogen synthesis and hepatic glucose-G6P flux control and thus whole-body glucose homeostasis.
UR - http://www.scopus.com/inward/record.url?scp=84891797370&partnerID=8YFLogxK
U2 - 10.2337/db13-0880
DO - 10.2337/db13-0880
M3 - Journal article
C2 - 23990365
AN - SCOPUS:84891797370
VL - 62
SP - 4070
EP - 4082
JO - Diabetes
JF - Diabetes
SN - 0012-1797
IS - 12
ER -
ID: 239216185